Cost-Effectiveness in Health and Medicine

Front Cover
Peter J. Neumann, Gillian D. Sanders, Louise B. Russell, Joanna E. Siegel, Theodore G. Ganiats
Oxford University Press, Oct 3, 2016 - Medical - 496 pages
A COMPLETE UPDATE AND REVISION OF THE CLASSIC TEXT "At last, a manual of operations for comparing the cost-effectiveness of a preventive service with a treatment intervention." --American Journal of Preventive Medicine Twenty years after the first edition of COST-EFFECTIVENESS IN HEALTH AND MEDICINE established the practical benchmark for cost-effectiveness analysis, this completely revised edition of the classic text provides an essential resource to a new generation of practitioners, students, researchers, and policymakers. Produced by the Second Panel on Cost-Effectiveness in Health and Medicine--a team of 13 experts from fields including decision science, economics, ethics, psychology, and medicine--this new edition is a comprehensive guide to the use of cost-effectiveness analysis as an evaluative tool at the institutional and policy levels. As health care systems face increasing pressure to derive maximum value from expenditures, the guidelines in this new text represent not just the best information available, but a vital guide to health care decision-making in a challenging new era. Completely revised and enriched with examples and expanded coverage, this second edition of COST-EFFECTIVENESS IN HEALTH AND MEDICINE builds on its predecessor's excellence, offering required reading for both analysts and decision makers.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

 Experiences since the Original Panel
1
2 Theoretical Foundations of CostEffectiveness Analysis in Health and Medicine
39
3 Recommendations on Perspectives for the Reference Case
67
4 Designing a CostEffectiveness Analysis
75
5 Decision Models in CostEffectiveness Analysis
105
6 Identifying and Quantifying the Consequences of Interventions
137
7 Valuing Health Outcomes
167
8 Estimating Costs and Valuations of NonHealth Benefits in CostEffectiveness Analysis
201
11 Reflecting Uncertainty in CostEffectiveness Analysis
289
12 Ethical and Distributive Considerations
319
13 Reporting CostEffectiveness Analyses
343
Summary of Recommendations by Chapter
369
Overview of Worked Examples
383
 The CostEffectiveness of Treatments for Individuals with Alcohol Use Disorders A Reference Case Analysis
385
 The CostEffectiveness of Home Palliative Care for Patients at the End of Life
431
Index
473

9 Evidence Synthesis for Informing CostEffectiveness Analysis
237
10 Discounting in CostEffectiveness Analysis
277

Other editions - View all

Common terms and phrases

About the author (2016)

Peter J. Neumann is Director of the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and Professor of Medicine at Tufts University School of Medicine. Gillian D. Sanders is Director of the Duke Evidence Synthesis Group at the Duke Clinical Research Institute, and Professor of Medicine at Duke University. Louise B. Russell is Distinguished Professor, Institute for Health and Department of Economics, at Rutgers University. Joanna E. Siegel is Director of Dissemination and Implementation at Patient-Centered Outcomes Research Institute (PCORI), Washington, DC. Theodore G. Ganiats is Professor Emeritus, Health Services Research Center and Department of Family Medicine and Public Health, at University of California, San Diego.

Bibliographic information